Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 24, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,379,704

« Back to Dashboard

Which drugs does patent 6,379,704 protect, and when does it expire?

Patent 6,379,704 protects VIVITROL and is included in one NDA.

This patent has nineteen patent family members in eleven countries.

Summary for Patent: 6,379,704

Title:	Method for preparing microparticles having a selected polymer molecular weight
Abstract:	A method for preparing microparticles having a selected polymer molecular weight. The hold time and temperature of a solution containing a nucleophilic compound and a polymer having a starting molecular weight are controlled in order to control the molecular weight of the polymer in the finished microparticle product. In this manner, a selected polymer molecular weight in the finished microparticle product can be achieved from a variety of starting material molecular weights.
Inventor(s):	Wright; Steven G. (Madeira, OH), Rickey; Michael E. (Loveland, OH), Ramstack; J. Michael (Lebanon, OH), Lyons; Shawn L. (Cincinnati, OH), Hotz; Joyce M. (Cincinnati, OH)
Assignee:	Alkermes Controlled Therapeutics Inc. II (Cambridge, MA)
Application Number:	09/870,751
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 6,379,704
Patent Claim Types: see list of patent claims	Use; Compound;

Drugs Protected by US Patent 6,379,704

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Alkermes	VIVITROL	naltrexone	FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR	021897-001	Apr 13, 2006		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 6,379,704

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	399535	➤ Sign Up
Australia	2001255465	➤ Sign Up
Australia	5546501	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.